CASP3 and cancer: Secondly, the released cytC reached 95% (compared to the native), as assessed by caspases-3,7 activity in LLC cancer cell lysate, which increased about 2.7-fold upon cytC addition, i.e., no inactivation of cytC macromolecules was observed due to their covalent binding to the crosslinker and PEG-FA polymer.